<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>AngioGenex, Inc. &#160;8-K 05-11-09</TITLE>
<META content=. name=author>
<META content=05/11/2009 name=date>
</HEAD>
<BODY
style="FONT-SIZE: 10pt; COLOR: #000000; LINE-HEIGHT: 12pt; FONT-FAMILY: Times New Roman">
<P style="FONT-SIZE: 14pt; MARGIN: 0px; LINE-HEIGHT: 16pt"
align=center><B>UNITED STATES</B></P>
<P style="FONT-SIZE: 14pt; MARGIN: 0px; LINE-HEIGHT: 16pt"
align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="MARGIN: 0px" align=center><BR></P>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt"
align=center><B>Washington, DC 20549</B></P>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt"
align=center><B>___________</B></P>
<P style="MARGIN: 0px">&nbsp;</P>
<P style="FONT-SIZE: 14pt; MARGIN: 0px; LINE-HEIGHT: 16pt" align=center><B>FORM
8-K</B></P>
<P style="FONT-SIZE: 12pt; MARGIN: 0px; LINE-HEIGHT: 14pt"
align=center><B>___________</B></P>
<P style="MARGIN: 0px" align=center><BR></P>
<P style="MARGIN: 0px">&nbsp;</P>
<P style="MARGIN: 0px" align=center><B>CURRENT REPORT</B></P>
<P style="MARGIN: 0px">&nbsp;</P>
<P style="MARGIN: 0px" align=center><B>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</B></P>
<P style="MARGIN: 0px" align=center><BR></P>
<P style="MARGIN: 0px" align=center>Date of Report (Date of earliest event
reported): May 4, 2009</P>
<P style="MARGIN: 0px" align=center>&nbsp;</P>
<P style="MARGIN: 0px" align=center><I>Commission File Number: 000-26181</I></P>
<P style="MARGIN: 0px"><BR></P>
<P style="FONT-SIZE: 25pt; MARGIN: 0px; LINE-HEIGHT: 27pt"
align=center><B><U>AngioGenex, Inc.</U></B></P>
<P style="MARGIN: 0px" align=center>&nbsp;(Exact name of small business issuer
as specified in its charter) </P>
<P style="MARGIN: 0px" align=center><BR></P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0 align=center>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=247></TD>
<TD width=48></TD>
<TD width=259></TD></TR>
<TR>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=bottom width=247>
<P style="MARGIN: 0px" align=center><B>Nevada</B></P></TD>
<TD vAlign=bottom width=48>
<P>&nbsp;</P></TD>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=bottom width=259>
<P style="MARGIN: 0px" align=center><B>86-0945116</B></P></TD></TR>
<TR>
<TD vAlign=top width=247>
<P style="MARGIN: 0px" align=center>(State or other jurisdiction of
incorporation or organization)</P></TD>
<TD vAlign=top width=48>
<P style="MARGIN: 0px">&nbsp;</P></TD>
<TD vAlign=top width=259>
<P style="MARGIN: 0px" align=center>(IRS Employer Identification
No.)</P></TD></TR></TABLE>
<P style="MARGIN: 0px"><BR></P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0 align=center>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=363></TD></TR>
<TR>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=bottom width=363>
<P style="MARGIN: 0px" align=center><B>425 Madison Ave., Suite 902, New
York, New York 10017</B></P></TD></TR>
<TR>
<TD vAlign=top width=363>
<P style="MARGIN: 0px" align=center>(Address of principal executive
offices)</P></TD></TR></TABLE>
<P style="MARGIN: 0px"><BR></P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0 align=center>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=275></TD></TR>
<TR>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=bottom width=275>
<P style="MARGIN: 0px" align=center><B>(212) 874-6008</B></P></TD></TR>
<TR>
<TD vAlign=top width=275>
<P style="MARGIN: 0px" align=center>(Issuer's telephone number, including
area code)</P></TD></TR></TABLE>
<P style="MARGIN: 0px"><BR></P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0 align=center>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=337></TD></TR>
<TR>
<TD style="BORDER-BOTTOM: #000000 1px solid" vAlign=top width=337>
<P>&nbsp;</P></TD></TR>
<TR>
<TD vAlign=top width=337>
<P style="MARGIN: 0px" align=center>(Former name, former address and
former fiscal year,</P>
<P style="MARGIN: 0px" align=center>If changed since last
report)</P></TD></TR></TABLE>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px" align=justify>Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (<U>see</U> General Instruction
A.2. below):</P>
<P style="MARGIN: 0px">&nbsp;</P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=57></TD>
<TD width=603></TD></TR>
<TR>
<TD vAlign=top width=57>
<P style="MARGIN: 0px">[ ]</P></TD>
<TD vAlign=top width=603>
<P style="MARGIN: 0px">Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)</P></TD></TR>
<TR>
<TD vAlign=top width=57>
<P style="MARGIN: 0px">[ ]</P></TD>
<TD vAlign=top width=603>
<P style="MARGIN: 0px">Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)</P></TD></TR>
<TR>
<TD vAlign=top width=57>
<P style="MARGIN: 0px">[ ]</P></TD>
<TD vAlign=top width=603>
<P style="MARGIN: 0px">Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P></TD></TR>
<TR>
<TD vAlign=top width=57>
<P style="MARGIN: 0px">[ ]</P></TD>
<TD vAlign=top width=603>
<P style="MARGIN: 0px">Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))</P></TD></TR></TABLE>
<P style="MARGIN: 0px">
<HR style="MARGIN-TOP: 9px; MARGIN-BOTTOM: 9px" noShade SIZE=1>
</P>
<P style="PAGE-BREAK-BEFORE: always; MARGIN: 0px"><B>Section 4. Matters Related
to Accountants and Financial Statements<A name=id_0_3></A><A
name=id_0_4></A></B></P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px"><B>Item 4.01 <A name=OLE_LINK1></A>Changes in
Registrant's Certifying Accountant</B>.</P><A name=TAB1></A>
<P style="MARGIN: 0px"><BR></P><A name=OLE_LINK2></A>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -16px">(1)</P>
<P style="MARGIN: 0px; TEXT-INDENT: 48px">Previous Independent Registered Public
Accounting Firm</P>
<P style="MARGIN: 0px"><BR></P>
<P
style="MARGIN-TOP: 0px; PADDING-LEFT: 96px; MARGIN-BOTTOM: -16px; TEXT-INDENT: -48px"
align=justify>(i)</P>
<P style="PADDING-LEFT: 96px; MARGIN: 0px" align=justify>On May 4, 2009,
AngioGenex, Inc. (&#147;Registrant&#148;) dismissed its independent registered public
accounting firm, Williams &amp; Webster, P.S. (&#147;Williams &amp; Webster&#148;).</P>
<P style="MARGIN: 0px"><BR></P>
<P
style="MARGIN-TOP: 0px; PADDING-LEFT: 96px; MARGIN-BOTTOM: -16px; TEXT-INDENT: -48px"
align=justify>(ii)</P>
<P style="PADDING-LEFT: 96px; MARGIN: 0px" align=justify>The reports of Williams
&amp; Webster on the financial statements of the Registrant as of December 31,
2008 and 2007 and for the years then ended did not contain an adverse opinion or
disclaimer of opinion and were not qualified or modified as to uncertainty,
audit scope or accounting principles other than an explanatory paragraph as to a
going concern.</P>
<P style="MARGIN: 0px"><BR></P>
<P
style="MARGIN-TOP: 0px; PADDING-LEFT: 96px; MARGIN-BOTTOM: -16px; TEXT-INDENT: -48px"
align=justify>(iii)</P>
<P style="PADDING-LEFT: 96px; MARGIN: 0px" align=justify>The decision to change
independent registered public accounting firm was approved by the Board of
Directors of the Registrant.</P>
<P style="MARGIN: 0px" align=justify><BR></P>
<P
style="MARGIN-TOP: 0px; PADDING-LEFT: 96px; MARGIN-BOTTOM: -16px; TEXT-INDENT: -48px"
align=justify>(iv)</P>
<P style="PADDING-LEFT: 96px; MARGIN: 0px" align=justify>During the Registrant&#146;s
two most recent years ended December 31, 2008 and 2007 and any subsequent
interim periods through May 4, 2009, (a) there were no disagreements with
Williams &amp; Webster on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of Williams &amp; Webster,
would have caused it to make reference thereto in its reports on the financial
statements for such years and (b) there were no &#147;reportable events&#148; as described
in Item&nbsp;304(a)(1)(v) of Regulation&nbsp;S-K. &nbsp;</P>
<P style="MARGIN: 0px" align=justify><BR></P>
<P
style="MARGIN-TOP: 0px; PADDING-LEFT: 96px; MARGIN-BOTTOM: -16px; TEXT-INDENT: -48px"
align=justify>(v)</P>
<P style="PADDING-LEFT: 96px; MARGIN: 0px" align=justify>On May 4, 2009 the
Registrant provided Williams &amp; Webster with a copy of this Current Report
and has requested that it furnish the Registrant with a letter addressed to the
Securities &amp; Exchange Commission stating whether it agrees with the above
statements. &nbsp;A copy of such letter is attached as Exhibit 16.1 to this
Current Report on Form 8-K.</P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -16px" align=justify>(<A
name=FIS_OTHER_EVENTS></A><A name=FIS_SIGNATURES></A>2)</P>
<P style="MARGIN: 0px; TEXT-INDENT: 48px" align=justify>New Independent
Registered Public Accounting Firm</P>
<P style="MARGIN: 0px" align=justify><BR></P>
<P style="PADDING-LEFT: 48px; MARGIN: 0px" align=justify>The Registrant has
engaged Li &amp; Company, PC (&#147;Li &amp; Company&#148;) as its new independent
registered public accounting firm to audit and review the Registrant&#146;s financial
statements effective May 4, 2009. &nbsp;During the two most recent years ended
December&nbsp;31, 2008 and 2007, and any subsequent period through the date
hereof prior to the engagement of Li &amp; Company, neither the Registrant, nor
someone on its behalf, has consulted Li &amp; Company regarding:</P>
<P style="MARGIN: 0px"><BR></P>
<P
style="MARGIN-TOP: 0px; PADDING-LEFT: 96px; MARGIN-BOTTOM: -16px; TEXT-INDENT: -48px"
align=justify>(i)</P>
<P style="PADDING-LEFT: 96px; MARGIN: 0px" align=justify>either: the application
of accounting principles to a specified transaction, either completed or
proposed; or the type of audit opinion that might be rendered on the
registrant&#146;s financial statements, and either a written report was provided to
the registrant or oral advice was provided that the new accountant concluded was
an important factor considered by the registrant in reaching a decision as to
the accounting, auditing or financial reporting issue; or</P>
<P style="MARGIN: 0px"><BR></P>
<P
style="MARGIN-TOP: 0px; PADDING-LEFT: 96px; MARGIN-BOTTOM: -16px; TEXT-INDENT: -48px"
align=justify>(ii)</P>
<P style="PADDING-LEFT: 96px; MARGIN: 0px" align=justify>any matter that was
either the subject of a disagreement as defined in paragraph 304(a)(1)(iv) of
Regulation S-K or a reportable event as described in paragraph 304(a)(1)(v) of
Regulation S-K.</P>
<P style="MARGIN: 0px" align=justify><BR></P>
<P style="MARGIN: 0px" align=justify><B>Section 9. Financial Statements and
Exhibits</B></P><A name=id_0_7></A><A name=id_0_8></A>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px" align=justify><B>Item 9.01 Financial Statements and
Exhibits</B></P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px">(a) Financial Statements of Businesses Acquired: None</P>
<P style="MARGIN: 0px">(b) Pro-Forma Financial Statements: None</P>
<P style="MARGIN: 0px">(c) Exhibits: </P>
<P style="MARGIN: 0px"><BR></P>
<TABLE style="FONT-SIZE: 10pt" cellSpacing=0>
<TR style="FONT-SIZE: 0px" height=0>
<TD width=84></TD>
<TD width=12></TD>
<TD width=576></TD></TR>
<TR>
<TD vAlign=top width=84>
<P style="MARGIN: 0px"><B>Exhibit No.</B></P></TD>
<TD width=12>
<P>&nbsp;</P></TD>
<TD vAlign=top width=576>
<P style="MARGIN: 0px"><B>Description</B></P></TD></TR>
<TR>
<TD vAlign=top width=84>
<P>&nbsp;</P></TD>
<TD width=12>
<P>&nbsp;</P></TD>
<TD vAlign=top width=576>
<P>&nbsp;</P></TD></TR>
<TR>
<TD vAlign=top width=84>
<P style="MARGIN: 0px">16.1</P></TD>
<TD width=12>
<P>&nbsp;</P></TD>
<TD vAlign=top width=576>
<P style="MARGIN: 0px">Letter of Williams &amp; Webster, P.S. dated May
11, 2009 to the Securities and Exchange
Commission.</P></TD></TR></TABLE>
<P style="MARGIN: 0px">
<HR style="MARGIN-TOP: 9px; MARGIN-BOTTOM: 9px" noShade SIZE=1>
</P>
<P style="PAGE-BREAK-BEFORE: always; MARGIN: 0px"
align=center><B>SIGNATURES</B></P>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN: 0px; TEXT-INDENT: 48px" align=justify>Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</P>
<P style="MARGIN: 0px"><BR></P>
<P style="PADDING-LEFT: 240px; MARGIN: 0px; TEXT-INDENT: 48px"
align=justify><B>AngioGenex, Inc. (Registrant)</B></P><A name=doc_0_2></A><A
name=page_0_2_1></A>
<P style="MARGIN: 0px"><BR></P>
<P style="MARGIN-TOP: 0px; MARGIN-BOTTOM: -16px">Date: May 12, 2009</P>
<P style="MARGIN: 0px; TEXT-INDENT: 288px"><U>By: /s/ Bill Garland</U></P>
<P style="MARGIN: 0px; TEXT-INDENT: 288px">Bill Garland</P>
<P style="MARGIN: 0px; TEXT-INDENT: 288px">Chief Executive Officer</P>
<P
style="MARGIN: 0px"><BR><BR></P></BODY>
<!-- EDGAR Validation Code: A6A59F21 -->
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "aggx8k051109apg.htm", "description": "ANGIOGENEX, INC. 8-K 05-12-09", "secsgml_size_bytes": 12985}]
{"company-data": {"conformed-name": "AngioGenex, Inc.", "cik": "0001085596", "assigned-sic": "2834", "irs-number": "860945116", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26181", "film-number": "09819047"}, "business-address": {"street1": "425 MADISON AVENUE, SUITE 902", "city": "NEW YORK", "state": "NY", "zip": "10017", "phone": "212-874-6608"}, "mail-address": {"street1": "425 MADISON AVENUE, SUITE 902", "city": "NEW YORK", "state": "NY", "zip": "10017"}, "former-company": {"former-conformed-name": "ECLIC INC/NV", "date-changed": "19990430"}}
AngioGenex, Inc.  8-K 05-11-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
___________
FORM
8-K
___________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): May 4, 2009
Commission File Number: 000-26181
AngioGenex, Inc.
(Exact name of small business issuer
as specified in its charter)
Nevada
86-0945116
(State or other jurisdiction of
incorporation or organization)
(IRS Employer Identification
No.)
425 Madison Ave., Suite 902, New
York, New York 10017
(Address of principal executive
offices)
(212) 874-6008
(Issuer's telephone number, including
area code)
(Former name, former address and
former fiscal year,
If changed since last
report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (
see
General Instruction
A.2. below):
[ ]
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Section 4. Matters Related
to Accountants and Financial Statements
Item 4.01
Changes in
Registrant's Certifying Accountant
.
(1)
Previous Independent Registered Public
Accounting Firm
(i)
On May 4, 2009,
AngioGenex, Inc. ("Registrant") dismissed its independent registered public
accounting firm, Williams & Webster, P.S. ("Williams & Webster").
(ii)
The reports of Williams
& Webster on the financial statements of the Registrant as of December 31,
2008 and 2007 and for the years then ended did not contain an adverse opinion or
disclaimer of opinion and were not qualified or modified as to uncertainty,
audit scope or accounting principles other than an explanatory paragraph as to a
going concern.
(iii)
The decision to change
independent registered public accounting firm was approved by the Board of
Directors of the Registrant.
(iv)
During the Registrant's
two most recent years ended December 31, 2008 and 2007 and any subsequent
interim periods through May 4, 2009, (a) there were no disagreements with
Williams & Webster on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of Williams & Webster,
would have caused it to make reference thereto in its reports on the financial
statements for such years and (b) there were no "reportable events" as described
in Item 304(a)(1)(v) of Regulation S-K.
(v)
On May 4, 2009 the
Registrant provided Williams & Webster with a copy of this Current Report
and has requested that it furnish the Registrant with a letter addressed to the
Securities & Exchange Commission stating whether it agrees with the above
statements.  A copy of such letter is attached as Exhibit 16.1 to this
Current Report on Form 8-K.
(
2)
New Independent
Registered Public Accounting Firm
The Registrant has
engaged Li & Company, PC ("Li & Company") as its new independent
registered public accounting firm to audit and review the Registrant's financial
statements effective May 4, 2009.  During the two most recent years ended
December 31, 2008 and 2007, and any subsequent period through the date
hereof prior to the engagement of Li & Company, neither the Registrant, nor
someone on its behalf, has consulted Li & Company regarding:
(i)
either: the application
of accounting principles to a specified transaction, either completed or
proposed; or the type of audit opinion that might be rendered on the
registrant's financial statements, and either a written report was provided to
the registrant or oral advice was provided that the new accountant concluded was
an important factor considered by the registrant in reaching a decision as to
the accounting, auditing or financial reporting issue; or
(ii)
any matter that was
either the subject of a disagreement as defined in paragraph 304(a)(1)(iv) of
Regulation S-K or a reportable event as described in paragraph 304(a)(1)(v) of
Regulation S-K.
Section 9. Financial Statements and
Exhibits
Item 9.01 Financial Statements and
Exhibits
(a) Financial Statements of Businesses Acquired: None
(b) Pro-Forma Financial Statements: None
(c) Exhibits:
Exhibit No.
Description
16.1
Letter of Williams & Webster, P.S. dated May
11, 2009 to the Securities and Exchange
Commission.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
AngioGenex, Inc. (Registrant)
Date: May 12, 2009
By: /s/ Bill Garland
Bill Garland
Chief Executive Officer